THOMAS C FREYMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THOMAS C FREYMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS C FREYMAN. THOMAS C FREYMAN is Executive Vice President in ABBOTT LABORATORIES ($ABT) and Senior Vice President in ABBOTT LABORATORIES ($ABT) and Director in HANGER, INC. ($HGR) and Director in TENNECO INC ($TEN) and Director in AbbVie Inc. ($ABBV) and Director in Allergan plc ($AGN).
Latest Insider Trading Transactions of THOMAS C FREYMAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, ABBV, AGN, HGR, TEN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | ABBV | AbbVie Inc. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 1,681 | 0 | 121,355 | 119.7 K to 121.4 K (+1.40 %) |
Feb 04 2021 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 10,850 | 0 | 78,782 | 67.9 K to 78.8 K (+15.97 %) |
Aug 07 2020 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Buy | P | 7.70 | 30,000 | 231,000 | 67,932 | 37.9 K to 67.9 K (+79.09 %) |
May 21 2020 | HGR | HANGER, INC. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 8,178 | 0 | 28,166 | 20 K to 28.2 K (+40.91 %) |
May 12 2020 | ABBV | AbbVie Inc. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 2,333 | 0 | 119,675 | 117.3 K to 119.7 K (+1.99 %) |
May 12 2020 | ABBV | AbbVie Inc. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 2,583 | 0 | 117,342 | 114.8 K to 117.3 K (+2.25 %) |
May 11 2020 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Sell | D | 0.00 | 2,983 | 0 | 0 | 3 K to 0 (-100.00 %) |
May 11 2020 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Sell | D | 0.00 | 2,983 | 0 | 0 | 3 K to 0 (-100.00 %) |
May 04 2020 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Payment of Exercise | F | 189.74 | 2,064 | 391,623 | 2,983 | 5 K to 3 K (-40.90 %) |
Feb 06 2020 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 12,208 | 0 | 37,932 | 25.7 K to 37.9 K (+47.46 %) |
May 24 2019 | HGR | HANGER, INC. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 6,969 | 0 | 19,988 | 13 K to 20 K (+53.53 %) |
May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Grant | A | 145.33 | 2,064 | 299,961 | 3,974 | 1.9 K to 4 K (+108.06 %) |
May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Payment of Exercise | F | 147.00 | 748 | 109,956 | 1,910 | 2.7 K to 1.9 K (-28.14 %) |
May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Grant | A | 145.33 | 2,064 | 299,961 | 3,974 | 1.9 K to 4 K (+108.06 %) |
May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Payment of Exercise | F | 147.00 | 748 | 109,956 | 1,910 | 2.7 K to 1.9 K (-28.14 %) |
Feb 07 2019 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 3,459 | 0 | 25,724 | 22.3 K to 25.7 K (+15.54 %) |
Sep 04 2018 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Buy | P | 190.69 | 1,100 | 209,759 | 2,658 | 1.6 K to 2.7 K (+70.60 %) |
Aug 10 2018 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Buy | P | 44.49 | 5,000 | 222,450 | 22,265 | 17.3 K to 22.3 K (+28.96 %) |
Jun 15 2018 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Grant | A | 170.23 | 1,558 | 265,218 | 1,558 | 0 to 1.6 K |
May 17 2018 | HGR | HANGER, INC. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 7,672 | 0 | 13,019 | 5.3 K to 13 K (+143.48 %) |
Feb 09 2018 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 2,180 | 0 | 17,265 | 15.1 K to 17.3 K (+14.45 %) |
Nov 17 2017 | HGR | HANGER, INC. | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 5,347 | 0 | 5,347 | 0 to 5.3 K |
Feb 03 2017 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 1,756 | 0 | 15,085 | 13.3 K to 15.1 K (+13.17 %) |
Aug 04 2016 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Sell | J | 0.00 | 2,757 | 0 | 0 | 2.8 K to 0 (-100.00 %) |
Aug 04 2016 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Buy | J | 0.00 | 2,757 | 0 | 13,329 | 10.6 K to 13.3 K (+26.08 %) |
Jul 29 2016 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | M | 25.25 | 56,000 | 1,413,782 | 0 | |
Jul 29 2016 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 44.45 | 42,863 | 1,905,260 | 395,819 | 438.7 K to 395.8 K (-9.77 %) |
Jul 29 2016 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Buy | M | 25.25 | 56,000 | 1,413,782 | 438,682 | 382.7 K to 438.7 K (+14.63 %) |
Feb 05 2016 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Grant | A | 0.00 | 2,757 | 0 | 2,757 | 0 to 2.8 K |
Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 39.52 | 19,908 | 786,764 | 382,682 | 402.6 K to 382.7 K (-4.94 %) |
Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 38.40 | 485,159 | 18,630,106 | 485,159 | |
Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Grant | A | 0.00 | 55,338 | 0 | 402,590 | 347.3 K to 402.6 K (+15.94 %) |
Jul 15 2015 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Sell | J | 0.00 | 2,000 | 0 | 0 | 2 K to 0 (-100.00 %) |
Jul 15 2015 | TEN | TENNECO INC | FREYMAN THOMAS C | Director | Buy | J | 0.00 | 2,000 | 0 | 10,572 | 8.6 K to 10.6 K (+23.33 %) |
Mar 03 2015 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Payment of Exercise | F | 47.61 | 22,797 | 1,085,365 | 347,252 | 370 K to 347.3 K (-6.16 %) |
Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Option Exercise | A | 47.00 | 284,857 | 13,388,279 | 284,857 | |
Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Executive Vice Pres ... | Grant | A | 0.00 | 40,425 | 0 | 370,049 | 329.6 K to 370 K (+12.26 %) |
Jan 26 2004 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Senior Vice Preside ... | Option Exercise | A | 43.70 | 23,199 | 1,013,796 | 23,199 | |
Jan 26 2004 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Senior Vice Preside ... | Option Exercise | M | 34.70 | 26,666 | 925,310 | 0 | |
Jan 26 2004 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Senior Vice Preside ... | Option Exercise | M | 19.57 | 10,216 | 199,927 | 0 | |
Jan 26 2004 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Senior Vice Preside ... | Payment of Exercise | F | 43.70 | 27,773 | 1,213,680 | 164,723 | 192.5 K to 164.7 K (-14.43 %) |
Jan 26 2004 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Senior Vice Preside ... | Buy | M | 34.70 | 26,666 | 925,310 | 192,496 | 165.8 K to 192.5 K (+16.08 %) |
Jan 26 2004 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Senior Vice Preside ... | Buy | M | 19.57 | 10,216 | 199,927 | 165,830 | 155.6 K to 165.8 K (+6.56 %) |
Jan 26 2004 | ABT | ABBOTT LABORATORIE ... | FREYMAN THOMAS C | Senior Vice Preside ... | Gift | G | 0.00 | 480 | 0 | 155,614 | 156.1 K to 155.6 K (-0.31 %) |
Page: 1